Exponent (NASDAQ:EXPO) Shares Down 4% – Time to Sell?

Exponent, Inc. (NASDAQ:EXPO) was down 4% during trading on Friday . The stock traded as low as $100.76 and last traded at $102.12. Approximately 28,659 shares traded hands during trading, a decline of 88% from the average daily volume of 245,406 shares. The stock had previously closed at $106.36.

Analyst Upgrades and Downgrades

Separately, Truist Financial reissued a “buy” rating and set a $120.00 price target (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Stock Down 7.0 %

The stock has a 50-day simple moving average of $109.16 and a 200 day simple moving average of $99.91. The company has a market cap of $5.01 billion, a PE ratio of 50.74 and a beta of 0.66.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, October 24th. The business services provider reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The firm had revenue of $125.09 million for the quarter, compared to analyst estimates of $125.96 million. As a group, research analysts anticipate that Exponent, Inc. will post 2.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, VP John Pye sold 3,956 shares of Exponent stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the completion of the sale, the vice president now directly owns 28,422 shares of the company’s stock, valued at approximately $2,984,310. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in EXPO. Bamco Inc. NY acquired a new position in Exponent during the 1st quarter worth $25,904,000. Vanguard Group Inc. increased its holdings in Exponent by 5.8% in the first quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after buying an additional 291,047 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in Exponent by 6.5% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after buying an additional 284,179 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Exponent during the 2nd quarter worth about $22,050,000. Finally, International Assets Investment Management LLC acquired a new position in shares of Exponent during the 3rd quarter worth about $11,261,000. Institutional investors and hedge funds own 92.37% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.